0001564590-21-047612.txt : 20210910 0001564590-21-047612.hdr.sgml : 20210910 20210910161708 ACCESSION NUMBER: 0001564590-21-047612 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20210907 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing FILED AS OF DATE: 20210910 DATE AS OF CHANGE: 20210910 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Iterum Therapeutics plc CENTRAL INDEX KEY: 0001659323 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38503 FILM NUMBER: 211247261 BUSINESS ADDRESS: STREET 1: BLOCK 2 FLOOR 3, HARCOURT CENTRE STREET 2: HARCOURT STREET CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: (872) 225-6077 MAIL ADDRESS: STREET 1: BLOCK 2 FLOOR 3, HARCOURT CENTRE STREET 2: HARCOURT STREET CITY: DUBLIN STATE: L2 ZIP: 2 FORMER COMPANY: FORMER CONFORMED NAME: Iterum Therapeutics Ltd DATE OF NAME CHANGE: 20151124 8-K 1 itrm-8k_20210907.htm 8-K_BID PRICE itrm-8k_20210907.htm
false 0001659323 0001659323 2021-09-07 2021-09-07

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

 

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): September 7, 2021

 

Iterum Therapeutics plc

(Exact name of registrant as specified in its charter)

Ireland

001-38503

98-1283148

(State or other jurisdiction

(Commission File Number)

(IRS Employer Identification No.)

of incorporation)

 

 

 

 

 

 

Block 2 Floor 3, Harcourt Centre,

Harcourt Street,

Dublin 2, Ireland


Not applicable

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: +353 1 903 8920

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12 (b) of the Act:

 

Title of Each Class

Trading Symbol

Name of Each Exchange on Which Registered

Ordinary Shares, par value $0.01 per share

ITRM

The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 

 


 

 

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

On September 7, 2021, Iterum Therapeutics plc, or the Company, received a letter from the Listing Qualifications Department of The Nasdaq Stock Market, LLC, or Nasdaq, indicating that, based on the closing bid price for the previous 30 consecutive business days, the listing of the Company’s ordinary shares was not in compliance with Nasdaq Listing Rule 5550(a)(2) to maintain a minimum bid price of $1.00 per share (the “Bid Price Rule”). Under Nasdaq Listing Rule 5810(c)(3)(A), the Company has a period of 180 calendar days, or until March 7, 2022, to regain compliance with the Bid Price Rule.  To regain compliance during this 180-day compliance period, the closing bid price of the Company’s ordinary shares must be at least $1.00 for a minimum of 10 consecutive business days.

 

In the event that the Company does not regain compliance with the Bid Price Rule prior to the expiration of the 180-day compliance period, the Company may be eligible for an additional 180-day compliance period. To qualify, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the Bid Price Rule, and will need to provide written notice of its intention to cure the deficiency during the second compliance period, by effecting a reverse share split, if necessary. If the Company is not able to meet these requirements, the Company will receive written notification from Nasdaq that the Company’s shares are subject to delisting. At that time, the Company may appeal the relevant delisting determination to a hearings panel pursuant to the procedures set forth in the applicable Nasdaq Listing Rules.  However, there can be no assurance that, if the Company does appeal the delisting determination by Nasdaq to the panel, that such appeal would be successful.

 

The Company intends to actively monitor the closing bid price of its listed ordinary shares and, as appropriate, will consider all available options to resolve the deficiency and regain compliance with the Bid Price Rule, including potentially seeking to effect a reverse share split.


 


 

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Iterum Therapeutics plc

 

 

 

Dated: September 10, 2021

 

 

 

 

By:

/s/ Corey N. Fishman

 

 

 

 

Corey N. Fishman

 

 

 

Chief Executive Officer

 

 

 

 

 

EX-101.SCH 2 itrm-20210907.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000 - Document - Template Link link:presentationLink link:calculationLink link:definitionLink 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 itrm-20210907_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity Central Index Key Cover [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Emerging Growth Company Entity Emerging Growth Company Entity Ex Transition Period Entity Ex Transition Period Entity File Number Entity File Number Entity Incorporation, State or Country Code Entity Incorporation State Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address Address Line1 Entity Address, Address Line Two Entity Address Address Line2 Entity Address, Address Line Three Entity Address Address Line3 Entity Address, City or Town Entity Address City Or Town Entity Address, Country Entity Address Country Entity Address, Postal Zip Code Entity Address Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre-commencement Tender Offer Pre Commencement Tender Offer Pre-commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Title of 12(b) Security Security12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name EX-101.PRE 4 itrm-20210907_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 5 itrm-8k_20210907_htm.xml IDEA: XBRL DOCUMENT 0001659323 2021-09-07 2021-09-07 false 0001659323 8-K 2021-09-07 Iterum Therapeutics plc L2 001-38503 98-1283148 Block 2 Floor 3 Harcourt Centre Harcourt Street Dublin 2 IE Not applicable +353 1 903 8920 false false false false Ordinary Shares, par value $0.01 per share ITRM NASDAQ true true XML 6 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Document and Entity Information
Sep. 07, 2021
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Sep. 07, 2021
Entity Registrant Name Iterum Therapeutics plc
Entity Central Index Key 0001659323
Entity Emerging Growth Company true
Entity Ex Transition Period true
Entity File Number 001-38503
Entity Incorporation, State or Country Code L2
Entity Tax Identification Number 98-1283148
Entity Address, Address Line One Block 2 Floor 3
Entity Address, Address Line Two Harcourt Centre
Entity Address, Address Line Three Harcourt Street
Entity Address, City or Town Dublin 2
Entity Address, Country IE
Entity Address, Postal Zip Code Not applicable
City Area Code +353
Local Phone Number 1 903 8920
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Ordinary Shares, par value $0.01 per share
Trading Symbol ITRM
Security Exchange Name NASDAQ
EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 1 96 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.iterumtx.com/20210907/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports itrm-8k_20210907.htm itrm-20210907.xsd itrm-20210907_lab.xml itrm-20210907_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "itrm-8k_20210907.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "itrm-8k_20210907.htm" ] }, "labelLink": { "local": [ "itrm-20210907_lab.xml" ] }, "presentationLink": { "local": [ "itrm-20210907_pre.xml" ] }, "schema": { "local": [ "itrm-20210907.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd" ] } }, "elementCount": 26, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "itrm", "nsuri": "http://www.iterumtx.com/20210907", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "itrm-8k_20210907.htm", "contextRef": "C_0001659323_20210907_20210907", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.iterumtx.com/20210907/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "itrm-8k_20210907.htm", "contextRef": "C_0001659323_20210907_20210907", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "verboseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iterumtx.com/20210907/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iterumtx.com/20210907/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iterumtx.com/20210907/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "verboseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iterumtx.com/20210907/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line1", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iterumtx.com/20210907/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address Address Line2", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iterumtx.com/20210907/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address Address Line3", "terseLabel": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iterumtx.com/20210907/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iterumtx.com/20210907/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iterumtx.com/20210907/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iterumtx.com/20210907/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iterumtx.com/20210907/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iterumtx.com/20210907/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iterumtx.com/20210907/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iterumtx.com/20210907/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iterumtx.com/20210907/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iterumtx.com/20210907/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iterumtx.com/20210907/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iterumtx.com/20210907/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iterumtx.com/20210907/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iterumtx.com/20210907/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security12b Title", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iterumtx.com/20210907/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iterumtx.com/20210907/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iterumtx.com/20210907/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iterumtx.com/20210907/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iterumtx.com/20210907/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" } }, "version": "2.1" } ZIP 13 0001564590-21-047612-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001564590-21-047612-xbrl.zip M4$L#!!0 ( "."*E.C(YGCN 0 &(6 1 :71R;2TR,#(Q,#DP-RYX MW_U^V\7?W@>FMS8 $HTE* M\@2X0AYZ4"H;!\'3TY,?+RB7*8UGJ7SWC?QI8[F@T&@666D+)A=!]9Q^6#;4& M)E9B)S=KB#0Y,&0;'>-4(XF5$G2>*[A)13*!!Y^#$SK MJC%4R J+):C/. &980(M,E+&3:[0CHN"KY^F1>?LZ7: D&T(-,E2H5#1%Z8I ML>ETP/GFRW,1]LR2%_5U)OE:60_Q1L#[TB-X(0R7")U@;+.H,PQ7XL;^<)_E MYIYPG$WYW.CA%G $B)_UD..1[:UC]^&9CX.0FKM 5PC5\BV_6H"HEW]'%.[L M-"_'V]Z>N!TSHZ$/V6]Y5$4T=K&.#BC/7OMVO LJ9W:WBF1"!%@0D3+09QY1 M'U<9PQRKU&:BGN]TAXA.C^T0HYHN#[;*;O3W2S!:I1R6>@*-.P&K*G@%(.HE M(%KULCV#1?%Z?*941Y*.QMW89UZ.-[P=%EN:?3;P!<"4M,/M=AC;!V'OM/AZ M($PP94LHA= O F1;5UM S^\)7;/#75#L6XO\V%YLNKJB.J,7[MBLM'%&TZ#_ MJH!:YXN3^7606F=,X]6U @ESGBJ+PZZYU2RC?)%NEO2BF2/'9F_W6AFB>OJ^ MAT2?%0JF]N)A2/_,;G\^P1<=M2[<[CY4@G*P8EA03NT60O,@K_J;B3.%C*V+ M8%=B5UDN(?Z;7]GW3(#42JQW*M(;ED.2!#.2LPZ"6V3[Y3:K+AH[07)^FL$" MV5OA>'/"'[X[!IE(,Q"*ZE2I7#VM@@^?^0:V?I65[](+*J>+?>99O]V%/NA M^HP:"K1\Q3Q&A3I4T=>N9#L77O=:[UZR%\%NK]VL5'MRL50<&5<_ %!+ P04 M " C@BI3 +WNLW(' ":40 %0 &ET$?,P=2\Z1K?7 47EI>M,L>M1LO0Y MN]>UZ5P'FA9##QB"XA_@"OH(!#_GP.R9AM;K\]^Q<7;>.SVW3KL?3TWCQ/KX M:Z]WWNLE /X,3PLD?L[!:;?7-;H?3LX2#1^@_1^<(3"\2C2$UMFIX4Q/+,.V M3DS#ZI^9_;[5[WU ENE E"0:T,6:X=F3#][:[X(2^?FZ+B($K<$-=J%K8TC M*#[3]V#HVEUP20AX%-T\\(@\Q)Z1TXU0"=?MG,3B<8]<+WAXT4FHMYHPTJ5L MIIN]GJ7'K3M1\]5>^QS&G)80__^]79D/Z$YU+A5/ 6V M(/#PN1<\>4OMP*,2=8'<%N*1%C?3Q%.:86J6T5UY3H>K 4"H!Z,$/:(I$'^_ M/0YS.?NZ:*&[:,:#X]S""2*\Y@#BB:%I=C_"6*J;J*,OZC ^B#K>9*'YZP4? M#QZ>+PA716]MC?SW@ MJP\&R9##K_Y ZS0O$?,89?&3P$! !#C3)WU;T'[]E\Q.50&9'1? #P_4$+70 M;V7S<-.IWHY2('(\3\4 M_'. #/Z)L?\]ON79*M-<(:1:'&\[QOSTRCJ<[E//X"2&''^Y3A.Z&>&;[90@ M.+['F3+3/"E4D914TK)9$"\Y@R-8;@B8A#^!$P9VEXP>VV IZ M4"7E9-^]L)967,8Z_Q'-L%A/N/X=G)=.=';?)JO\-%9KB_PM#1 \QT]SH0OT MD$*J*4[JBWW<_6"Z\ I;01EC\'J.V R[L]\9??&?!G2^@&[%'7<.1)-\9$*V M-C!C-A#2@8A/E0%:;!$MJ9NB=I!F3D@9 JLQOTYX6+PZ$LY_%?.?T;^1VGMX M[25_!;92O3.SS;:%EY%+1 M) ?1E1O\$$W2WG$\2J13S9KXFN6YS6(BTH M0,BA2I(S5*=%JJBD,*DNKHR@#EV;L@5EP4O6(Y]O109TR1=&ZP%U*NX4#D U M$;L0NK6$IUC?@X 74 8B;B#(58E^.1]I15$5]XSDVQ6Y5NQ?] MN<4N,JH-ATR )IIG +8V#"*2]_&!>.,? O>N,E-&D3VTE&I*6D&R7$B98+QV M[,VFL3=E:VV^:QMZ2K;7UVK'G>BI\ MO;?*!M]J(_B2S#@@\Q:N_<@++K$O%FR*A3W# ME*RH[ZJEH '9,0^DOS\DOA&/^\J0-\1ZA7"'1*KE>L>&S% G)5)- M\IPX'Q);8I(?J.=#\C=>5+_3F8T@0>(48OO9#ND YU/J7F:A05E)SY!-33.R M4U_:AH;O[1:GQA"LDO=TGYKO[$Y@R,]T, ,*>$4BG*DRS5-"%45)-3&;!5%\ M0I(\/%&WXDND^_WJR;>+(S^4 0,(*)2Y]YVK.BU2126%275QFP7U+X9]'[D# M.I\OW>C.N5L8DK)9SNI93]-])/DIWG* F.3X$2X0GQ9+HY;0I(;&S6+[P) 8'XC+ M&WS827P:EMU/I^47#D4(]=3-1Y0?9\ZEV0DR$+*!@.[XP2YA#RTGFII6D(T+ M8%#=!:G1'WK>$K'F R #1XKV>[BO,!A"3K7'1+YOV2,C1T>5/QWZ_FC+N#(S_\ 2R@4V"8;R?O0$QX_+SG2D^+I%%) MYGA9LP4' 7I;81TS*+Y0;+2>3VCI9?A.IWKZI4!:R&@(#T+\XTLJY=EZO["=^HJC*YT2S^S8;W$FL%C:($0N(:13YG&BA"_200JHI3BJ) MG7SBEA^)K_R+GL+AU^!]_A]02P,$% @ (X(J4P()$)DQ!0 BC !4 M !I=')M+3(P,C$P.3 W7W!R92YX;6SM6N]OXC88_CYI_X.7?;G3EM_E6E"Y M$Z/MA$9[%;#MM"\GDQBPSK&1'0K\]WL="($2KM FU:H,584D[_OZ\9,WCU\[ MOORTB!AZ(%)1P9N&:SD&(CP0(>7CIC%3)E8!I092,>8A9H*3IK$DROCT\<S^=6.*)<"3:+H75E!2*RD6FFH=N28'T!7>&8H.330)[CN:93A[^! M>]%P:@V_9IW7//?,/__%<1J.LQ7@KU6WT-:G@6J68[G6A[.++<-[''S#8X(Z M5UN&V+^HN>'HS'<#_\QS_?J%5Z_[=><#\;T0D^V&VF*ZE'0\B=&[X'T"$?K+ M.6&,+-$-Y9@'%#/43WOZ*^KPP$(MQE!/NRG4(XK(!Q):ZZ@,>&NPE#RX1UPE MATUCB[W%4#)+R+'M.8YOI];&VGRQ9S_W$VNW7J_;R=6-J:)YAA#6M;_<=OO! MA$38A%L%61#H!A1MJ.1D5P3)/3H"%SIHH8_,U,S4ITS7,WW76JC0 #806O$A M!2,],D+Z^\]>9Z=-&A,YB^)%DD3Z#CAUY]S6EO: 1%,&*=1=]3@)-9%DU#1H M+",S-=:M_9QG&R^GD/6*PA7HN_TB0#%>""ZBY0I9^E"DWRT>7O.8QLL.'PD9 M)$NAP=Z82LI#'B;4F8,>!+&+"0Q*F870'RNEP@BC%Q$2P0X!N M4$&+208I$EAC\6"'A"8MZA\).PDSL,!C=G)7&5^A<*ZEZ0M M(LB8@.BTZ2@U(W*@\U%^'HV(/!;FTW'*A/URP.5!A;&)!C2&O+H%^9,P7!U] MZW,\"X7V-R06:(_F8<;I:KQ1QZ([X%PH0#T(LOL)%$=WLVAX_,W=]RL45AN> MQQ;44&T1'OT<[_H4"F_/PL!V+.GX=PR[T\D.LO*"J(_RR8NP%>!:CW4J#>*P%U7PK4+07H "\Z M(8Q9=+26W=/$\8D@)0"&.9F04R&3=OI0!I/UXWNZ1CT1J@3P-Y2=./KL^Y4 MZWH!U2I75/-P#\6!"$^#E^=?!LR(R#%4,+]+,8\G4"Q,,3]1\0^$* %L&YX' MB5D'2L'%'^1$F'O.)0#LD3%5T J/3YENY?L6"B^==JXRZ9J'>F7I6'P'G L% MV((&0MW(#PL>NXM8:PM[BB7$,X,)91NM&TD1Y6)9MR;RB!,2IGI-PW4< MU[$9G3'B5Y61 R*4,5,KFAF8TK\!7O('CXR6\RK3LC?F9[S4J\S+@9)MPXY; MN/"^*79R2N^,FL(5^"U1LSUIRBBIM/0^,>/-6*JT$A]5%N3<5>*,FTHK<\Y"?\9,I=7X\4N:C);_17CO!=N&'+^B*KS[ M:C2CHZ+"N__R.J.DHGI[8*]!QDM%U39OATA&2D6U]GL[>S;DG%54:Y_>IY51 M5%']W=]QEU%24?U]M#$RXZ.JNIN[@36CY164]]+>8P5F9]_T%O?5%?U/;_O^ M^"]02P,$% @ (X(J4\O&7$/7$@ ?I4 !0 !I=')M+3AK7S(P,C$P M.3 W+FAT;>U=ZW/B2)+_?!NQ_T,=LS-AQQHA"; !/S;XS\L>'JT_D+'"B(?,5*9.!4F&K4AF-1H;;Y[X,O$A!.])P@F&% ME,MIQ6W!*":0,ZH8T7\M8INV53:;\%_7:K3,>JM:-P[JME6K'OS3-%NFF:G@ M?^,!D,Q?B]0-T[",_5HCD_$K=;[3&T8Z9YF,M-JH6VZ_5K6<:LVVJLV&W6Q6 MF^8^J]HN9=F&VD$X%OQFH,B.LZN["./U?>9Y;$PNN$]]AU./7*F6;D2PUS-7#$1#=6=9@6.PVR:!VGN2);5.&1R4J)/94]7 MG:948NY8Y:J5*71#:5A8!A,*BD@5BGSW)7.,F^"V@BFZP"2K4(OZ-$DJ:D&H MP@)%6;FSH"_ M*QXK M8S8FM-K+LHVXDP@U(,GW' 5&55V!U6PV*SIU(G%*+-269@52TXQS5>;U"I-[ M5$[TBLL 8.!@F2;&.29]EKRHQY#5JOSQ^=.U,V!#6IY57WZWJ 4+=1T1%0%U M(G: ,]'P'MF 3&5-6.Y,RMU?*%^ WZGB M,^592@ONP'8J@9B%VNETV[;.]G M*BF#E.0J2J7FOGH:4ZU<+ B(FR4-H(RZ^.^0*:HM3IG]%?';XU([\$':5+D+ M8RP1)WXZ+BD0PHHN32I83G'E,?B!$%EN?/]W"H8&Y('D2II^5$E;0D-P^1%L M@0^&$W"4W**IL8UZ:BEZ@3L^.7+Y+9%J[+'CDLMEZ-$Q\I!AI__KB-^UL#HF M\"E^Y*[+?/VHGR'O9,QN[=>;5;LZ&=+D1^FD3SW)CBJY=NYKNY9M^]P'PHS;T+B@7L=WV=UO M;+Q>'Z:I11W1[S)$P7X)UF<(44PF?475;4FM7] DT?#00J$^+DD^##U4-OUN M(+!'FL<3!M])-TVFPA$!"H4^XH M GJ._X:IL@^IN.%^N127GZQ]\_"H$N::U#52C]_XK3\C"40? M'^9[8=GSW$[:7SY_[EQ?=[Y<_DBC_9W* #OD3.C;< ,M5YKOO (:\\YPHLO M5Y_)8A?%S+HH:20BXP"NZ)DTRK_-NB3K$G%%W-^$E(!&7)U?=LG5^= M/(?4==/GW/RA12,5'":>L!-X'@TE:Z4_#LF(NVK0JM>P_4,="%%Z.J+WA44>Y3I%>29M+&H$?H$Q^7JB5RJWD _ C"TMJJE'?ZKP./N\0T#M#I M3X@T8><\-Y-'C_65?LZS%U_,,1$Z'HC63[';\&((N5C+JO/1E2MVPR76JRXA M93T7IJ,#_*0[8(*&+%+G;6KLVLQ_'F"6%TY_R.@N%"QB!ZB@E# M")5$ALS!^(9+N$^XD@1,'<8#=Y<1]:D(N?]0E5E'1S:O%8UYK>CX3B# ;.F0 M\;4" ]*.ER':@?MP2X31ZA9S;Z@(17";+&R@-?K[WSJ">=1WEZG.EK'K,O9@ MGK$7W&.0$PS_NG%DJUQMU,VY,/*60X_A4'.>0UUZUTFBNHY6OX>PJ]DH6W:C M:M4:]_ K%PV,!Y'0MF4N\4B>RU19IF&]9M9[+^\$+G._$)A=> ,[9W#QE;W'P MU;)6Z8Z]7G=^I0(FN$(1O7UG;AO0WD,BX>]/4.Q5.%-](&>N@2],%0C*EC4K ML*8@EIKPI T_OXAN,/+78\Q9U/.X3^QU5+=@OUS:BSB\]+A@51*CPB8P3O4" M4:J7$*3-N/!'/4$J#UKC?W_*55\HUE\#J:CW?SQ<.Q)[!T^_ZN9E^XD;,&5BU# %)6'U"/LCCD1GN&!US"Y9W(;_(BI!7)+ M4'"+HQPK2MO[72J;+E;^\E/#M@X.)5',8^$ RA!?A]GV,$[B10B*A I&@6PN M:Y'8]MX+Q*7"H]Q7'^I"0 MN$6:9I4TFK;YE,CWXK+XT$T4S>6SVHK>27'R1#NMXQ9?>#-QZ:0]8# %Q-U1 M8.9$ 'B,H?I><$=ZS M&A,=;IRX@/VF4?R-][J&:< DZHQ@,P<7M8Y(/(T]1 MGP61],9$4L5E?ZQ+)@4"\%-OXHAMLALKLV@=03V"4'^NYX#^$UU9"&8Y_89_"ZX IW#M:+(3]8_Y.,F:[T@\'H4E$V! MRJ,$-@]JM<,%1F=5AVPUIC\9_5:+4<9<+9TD1 2J9:E(PLQFV*L(U*MFUQ-< MFMDZBCM&=ZP#TKZX(G;5-"#C;CQ/F[$4VD[,68FM7F_UVK1RFQAP=NZ 5JG74^HI!&\1ELU6K;LC%+G-H%/5+IF&G'.W7LT>7729%W4 M6+^R7DB+>^PA93\IABYU:(O@J&?@*>S=5GC=!5%U_Z_36G@%MLR7,^ M']8HG0"9RTZ&SO>Y%;':6C6W;._T=E?#HCCO[BQ-MZ"T!:77#TK6$E#J2!DQ ML86F5P5-55:NX252JT!3DO?)H6G=0U"+0>A-QH$RD\TX2,8$*13DT&=[SJ6C-J2:\VL[;R\I*: R!=SF5.LMVTI1$$KU2"C%V\ MK0CE])PZ ]+VJ)3+@7AS;+1-H[IEXP(V"JI7R6(WXK5RL%;?6'4S)[P,.;ZXF]J: N8NVUF\A]R4YO=#5SFW\2WR(L67W-/:NM_#[10"] MJ1B3ZP$53.Z1D ID=\3(/TS#M$B(5V]AVHK[NK9P_BI$)+:?J?C. M%/GTJ;W"-I+MK/&!O._X+L[M8>HU)H[>U0%]_4Y& Z8/7"2@,/ @ TW MZ-"!2H[4 $,$(6[#H)*XK \>@[Y#(%X/->MD_AZ=Z?4Y5;*#-#PXU&NB:6:N M;Q\(\?8!//\9K\/8O;)=4%?1G3R32C'<,"V7J=;8X(SW3SP<3%P0/ MEQW.+MB$F[;W43?7CEM[^DC?_K)(WU8^UL"1_A)DP*V2A3##YS9U#0!$F,<< M!2#B!SIL%4FF<[&[=.L8]HCK4%9\X2FR6K?EC;'Q$8>F43A]&"ZD"';+)93K M3ZZTIXX^;X"9\1IKEPI7QIO&W$4QL^H.G83,LIACQ+Q+./@4VK!?H UWW;4"G>B [I$>#!IR2G]D,@^W4"&;_\5&\>$JV9??"5H-8DY],!^8MO M?/_BD[D;Z_;(@ONW]I :"(CM%.<%5(J_D\$,ZG^ M9$'IC(54*+W4! 1<, O8PVF ;BU.G!@4K% -*&3 2\==#$EA6_@Y%TSJ<1ZNW.ZNY>EDK;C-#7/Z)8W@-[48Z@X"8V!(VB#/>2Q,TB$ MS=Y#+02'@!;0$1O(=S9G?;M%!5V8*&@A >\?.E&&MK/)<0_W%DC-BJP?1E*1 M'B-4@=13^!VS F5NRBLDPA*9>Z$9R2I&]2W@5"=6]/CB3T2 G/2Y 8N5<65! M0H8C1 2)JQERD3MW<(_HI T/(0L( AB7&_PP3"P"H+&NJWTW<#T75F00D-^_ M-#B.\Y6.N.=AK0*_!2+BLQ-#QN(A.Q,SE>)5DDU#*K8_C ,I<2 63\_AZ5_' M QUEGIN*,%@T @YAF,_B$27N-QDE6ZW]B:W&VPCUN1%='V1UM+&&2C'K,UR0+$MU6<"^Q##F1C>YC4C;R(2BL[(\ 9V44=C3J/-Z?5_',H!:-!5B>4C;I. YG+R:5C,#P))6,@@C4H8?4=9#]_# . E<0/*[2UJ.C(173D9DPLP,4>!A@SY\WV8LU"B\KU M23!XH+?@RFO!"\+8O]3>A R\VSG$0 1:V3YD3WN&@<8B: ^ZQ]AWC3M!@BS% ML/(TDK21H_.%EPELI]^;;O*^-:G7_&6/Z\['R]/NMZOSY72T&O-#V!B\96F7 M?D'GZXQ-S/H *RY5Q* VU('-O:)@J!L!RC@TPMFMGL3$M]QCDVBK@/_QM!>Q ML\<&U.NCR<.*] :.) /:5IAL!7%U-%*#0 176.Z"^^5;KN^?X5W=H%WZ>IN MS;#G]GZ\Q&'QM6YH>YZQVT:U\5Q#WXS#44C(13<&/ ]1Z]5GI.J&HJ7%5^VO M=EGJ&U3;5R2[6Q#8@L!KI>K""UM,HQJO8F_1X%%?.');F:47RTR_%K0%B"U MO FJ/IM;D--ZDK^C4.H["F&B'.\*"?&C6^H')_33TS96^BUIGX&TU?K=S MX+=-R.K[D,A%MR\_TUS!U%;L1Z+J,@.U!=*WJ__/"J2:%+BYB#N/).WK)^2S M NGK(>062!]][S)G?7(^N?3^B[[T7FST0.0C3F^\^GU4]S=IOWR3*VQ$>?9] M.4>57N".M: -U-"#'_\/4$L! A0#% @ (X(J4Z,CF>.X! 8A8 !$ M ( ! &ET'-D4$L! A0#% @ M(X(J4P"][K-R!P FE$ !4 ( !YP0 &ET,#DP-RYH=&U02P4& 0 ! ' 0 ^20 end